Imunon, Inc.

0.50 USD
-0.04 (-7.41%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Imunon, Inc. stock is down -15.25% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 32.26% of the previous 38 February’s closed higher than January.

About Imunon, Inc.

Celsion Corporation focuses on the development and commercialization of DNA-based immunotherapies and vaccines. Its product pipeline includes GEN-1 and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin.